Alpha Teknova (TKNO) Cash from Investing Activities Growth (1y) (2021 - 2026)
Alpha Teknova (TKNO) Cash from Investing Activities Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -308.05% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -41.51% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -139.86% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 129.18% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.71% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -366.90% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -96.43% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alpha Teknova | 374.37 Mn | 356.94 Mn | 4.89 Mn | -4.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.09% |
| Mar 31, 2026 | -51.86% |
| Dec 31, 2025 | 326.80% |
| Sep 30, 2025 | 106.37% |
| Jun 30, 2025 | 1,863.48% |
| Mar 31, 2025 | 29,315.38% |
| Dec 31, 2024 | -1,129.57% |
| Sep 30, 2024 | -2,550.10% |
| Jun 30, 2024 | 95.08% |
| Mar 31, 2024 | 100.30% |
| Dec 31, 2023 | 97.57% |
| Sep 30, 2023 | 85.23% |
| Jun 30, 2023 | 78.59% |
| Mar 31, 2023 | 27.13% |
| Dec 31, 2022 | 36.18% |
| Sep 30, 2022 | -68.47% |
| Jun 30, 2022 | -133.63% |
| Mar 31, 2022 | -287.24% |
| Dec 31, 2021 | -178.86% |
| Sep 30, 2021 | -2,046.70% |